A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/416 (2006.01) A61K 38/45 (2006.01) A61P 3/04 (2006.01) A61P 3/10 (2006.01) A61P 5/50 (2006.01) C12Q 1/48 (2006.01)
Patent
CA 2477842
A method of treating a metabolic disorder associated with insulin resistance by administering to a mammal an inhibitor of a NH2-terminal Jun Kinase (JNK), e.g., a compound or peptide which inhibits JNK1 expression or enzymatic activity.
L'invention concerne un procédé permettant de traiter un trouble métabolique associé à la résistance à l'insuline. Ce procédé consiste à administrer à un mammifère un inhibiteur d'une kinase JNK (NH2-terminal Jun Kinase), par exemple, un composé ou un peptide qui inhibe l'expression de JNK1 ou l'activité enzymatique.
Chang Lufen
Hotamisligil Gokhan S.
Karin Michael
Gowling Lafleur Henderson Llp
President And Fellows Of Harvard College
Regents Of The University Of California
LandOfFree
Inhibition of jun kinase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of jun kinase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of jun kinase will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1801515